Editorial
Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
Translational Cancer Research
2022;
11
(11)
:3929-3931
.
(29 November 2022)
Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients
Translational Cancer Research
2022;
11
(11)
:3932-3934
.
(29 November 2022)
The contributions of hypoxia to poor outcomes in pancreatic cancer
Translational Cancer Research
2022;
11
(11)
:3935-3937
.
(29 November 2022)
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges
Translational Cancer Research
2022;
11
(11)
:3938-3940
.
(29 November 2022)
Original Article
DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: pharmacological implications
Translational Cancer Research
2022;
11
(11)
:3941-3950
.
(29 November 2022)
Surgical therapy and survival in young patients with stage I–II hepatocellular carcinoma: a retrospective cohort study
Translational Cancer Research
2022;
11
(11)
:3951-3963
.
(29 November 2022)
Stereotactic body radiotherapy using helical tomotherapy for hepatocellular carcinoma: clinical outcome and dosimetric comparison of Hi-ART vs. Radixact
Translational Cancer Research
2022;
11
(11)
:3964-3973
.
(29 November 2022)
Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database
Translational Cancer Research
2022;
11
(11)
:3974-3985
.
(29 November 2022)
Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas
Translational Cancer Research
2022;
11
(11)
:3986-3999
.
(29 November 2022)
Comparison of bronchial methylene blue staining and modified inflation-deflation method in identifying the intersegmental plane during lung segmentectomy
Translational Cancer Research
2022;
11
(11)
:4000-4008
.
(29 November 2022)
A multidimensional model incorporating radiomics score and liquid biopsy for the prediction of malignant and benign pulmonary nodules
Translational Cancer Research
2022;
11
(11)
:4009-4018
.
(29 November 2022)
Prognostic biomarkers of pancreatic cancer identified based on a competing endogenous RNA regulatory network
Translational Cancer Research
2022;
11
(11)
:4019-4036
.
(29 November 2022)
Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(11)
:4037-4050
.
(29 November 2022)
Prediction of BRAF V600E variant from cancer gene expression data
Translational Cancer Research
2022;
11
(11)
:4051-4056
.
(29 November 2022)
Comprehensive bioinformatics analysis for MEF2 family genes in gastric cancer
Translational Cancer Research
2022;
11
(11)
:4057-4069
.
(29 November 2022)
Whole-genome identification and construction of the lncRNA-mRNA co-expression network in patients with actinic keratosis
Translational Cancer Research
2022;
11
(11)
:4070-4078
.
(29 November 2022)
The feasibility of MRI texture analysis in distinguishing glioblastoma, anaplastic astrocytoma and anaplastic oligodendroglioma
Translational Cancer Research
2022;
11
(11)
:4079-4088
.
(29 November 2022)
Multiomics analysis of ferroptosis-related molecular subtypes in muscle-invasive bladder cancer immunotherapy
Translational Cancer Research
2022;
11
(11)
:4089-4104
.
(29 November 2022)
Knockdown of Nrf2 radiosensitizes glioma cells by inducing redox stress and apoptosis in hypoxia
Translational Cancer Research
2022;
11
(11)
:4105-4116
.
(29 November 2022)
Inhibitory role of puerarin on the A549 lung cancer cell line
Translational Cancer Research
2022;
11
(11)
:4117-4125
.
(29 November 2022)
Down-regulation of CX43 expression by miR-1 inhibits the proliferation and invasion of glioma cells
Translational Cancer Research
2022;
11
(11)
:4126-4136
.
(29 November 2022)
The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma
Translational Cancer Research
2022;
11
(11)
:4137-4147
.
(29 November 2022)
The efficacy of mindfulness-based stress reduction vs. standard or usual care in patients with breast cancer: a systematic review and meta-analysis of randomized controlled trials
Translational Cancer Research
2022;
11
(11)
:4148-4158
.
(29 November 2022)
The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(11)
:4159-4177
.
(29 November 2022)
Case Report
Usefulness of neuroimaging and immunohistochemical study for accurate diagnosis of parasagittal hemangioblastoma arising in the supratentorial region: a case report and review of the literature
Translational Cancer Research
2022;
11
(11)
:4178-4184
.
(29 November 2022)
Trastuzumab treatment of invasive breast ductal carcinoma induces severe edema: a case report
Translational Cancer Research
2022;
11
(11)
:4185-4188
.
(29 November 2022)
Case report: cotyledonoid dissecting leiomyoma in a 49-year-old woman
Translational Cancer Research
2022;
11
(11)
:4189-4193
.
(29 November 2022)
Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review
Translational Cancer Research
2022;
11
(11)
:4194-4199
.
(29 November 2022)
Abscopal effect in a patient with solitary extramedullary plasmacytoma of the thyroid: case report
Translational Cancer Research
2022;
11
(11)
:4200-4205
.
(29 November 2022)
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
Translational Cancer Research
2022;
11
(11)
:4206-4217
.
(29 November 2022)
Erratum
Erratum to silencing of DHX32 increases the proliferation of liver cancer cells
Translational Cancer Research
2022;
11
(11)
:4218-4219
.
(29 November 2022)
